{"id":"NCT01332149","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy","officialTitle":"An 11-week Randomized, Double-blind, Multi Center, Placebo-controlled Study To Evaluate The Efficacy, Safety And Tolerability Of Pregabalin (300 Mg/Day) Using A Fixed Dosing Schedule In The Treatment Of Subjects S With Pain Associated With Diabetic Peripheral Neuropathy.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2014-04","completion":"2014-06","firstPosted":"2011-04-08","resultsPosted":"2015-06-19","lastUpdate":"2021-01-28"},"enrollment":626,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Neuropathy, Painful"],"interventions":[{"type":"DRUG","name":"Pregabalin","otherNames":[]},{"type":"DRUG","name":"Placebo matched with pregabalin","otherNames":[]}],"arms":[{"label":"300 mg/day pregabalin (Lyrica)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Pregabalin has proven effective in previous clinical trails in other countries in relieving neuropathic pain associated with postherpetic neuralgia and painful diabetic neuropathy.\n\nThis study is being conducted according to China registration requirement to submit a reapplication with new local diabetic peripheral neuropathy study as a commitment plus the existing data to apply for Lyrica \"pain associated with postherpetic neuralgia\" indication after Lyrica \"pain associated with postherpetic neuralgia\" is approved.","primaryOutcome":{"measure":"Baseline Mean Pain Score","timeFrame":"Baseline","effectByArm":[{"arm":"Pregabalin","deltaMin":6.65,"sd":1.117},{"arm":"Placebo","deltaMin":6.67,"sd":1.15}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":30,"countries":["China"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081265&StudyName=Study%20To%20Evaluate%20Efficacy%2C%20Safety%20And%20Tolerability%20Of%20Lyrica%20In%20Patients%20With%20Painful%20Diabetic%20Peripheral%20Neuropathy"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":314},"commonTop":["Dizziness","Somnolence","Urinary tract infection","Diarrhoea","Upper respiratory tract infection"]}}